| Field | Row 1 |
|---|---|
| adsh | 0001410578-25-001112 |
| cik | 1628808 |
| name | PROFOUND MEDICAL CORP. |
| sic | 3841 |
| countryba | CA |
| stprba | ON |
| cityba | MISSISSAUGA |
| zipba | L4W 5K5 |
| bas1 | 2400 SKYMARK AVENUE, UNIT 6 |
| bas2 | |
| baph | 647-476-1350 |
| countryma | CA |
| stprma | ON |
| cityma | MISSISSAUGA |
| zipma | L4W 5K5 |
| mas1 | 2400 SKYMARK AVENUE, UNIT 6 |
| mas2 | |
| countryinc | CA |
| stprinc | ON |
| ein | 000000000 |
| former | PROFOUND MEDICAL INC. |
| changed | 20141222 |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250508 |
| accepted | 2025-05-08 16:33:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | prof-20250331x10q_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001410578-25-001112 | 20241231 | Cash And Cash Equivalents At Carrying Value | 54912000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Common Stock Shares Issued | 24428899.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001410578-25-001112 | 20250331 | Contract With Customer Liability Noncurrent | 85000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Depreciation | 103000.0000 | USD | 1 | us-gaap/2024 | Geographical= U S; | ||
| 0001410578-25-001112 | 20241231 | Finite Lived Intangible Assets Net | 261000.0000 | USD | 0 | us-gaap/2024 | Geographical= C A; | ||
| 0001410578-25-001112 | 20250331 | Foreign Currency Transaction Gain Loss Before Tax | 38000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -6545000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Income Taxes Paid Net | 11000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Increase Decrease In Deferred Revenue | -107000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Increase Decrease In Deferred Revenue | 252000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Interest Paid Financing Activities | 56000.0000 | USD | 1 | 0001410578-25-001112 | |||
| 0001410578-25-001112 | 20250331 | Liabilities And Stockholders Equity | 60864000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Net Cash Provided By Used In Operating Activities | -8283000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Net Income Loss | -6585000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001410578-25-001112 | 20250331 | Net Income Loss | -10724000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Profit Loss | -10724000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Property Plant And Equipment Net | 332000.0000 | USD | 0 | us-gaap/2024 | Geographical= U S; | ||
| 0001410578-25-001112 | 20240331 | Repayments Of Long Term Debt | 623000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Retained Earnings Accumulated Deficit | -245170000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Revenues | 104000.0000 | USD | 1 | us-gaap/2024 | Geographical= C A; | ||
| 0001410578-25-001112 | 20250331 | Revenues | 250000.0000 | USD | 1 | us-gaap/2024 | Geographical= U S; Product Or Service= Capital Equipment; | ||
| 0001410578-25-001112 | 20250331 | Stockholders Equity | 2845000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001410578-25-001112 | 20240331 | Stock Issued During Period Shares New Issues | 3058334.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001410578-25-001112 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | 2845000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Amortization Of Intangible Assets | 229000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Amortization Of Intangible Assets | 229000.0000 | USD | 4 | us-gaap/2024 | Geographical= C A; | ||
| 0001410578-25-001112 | 20250331 | Amortization Of Intangible Assets | 47000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Assets | 92000.0000 | USD | 0 | us-gaap/2024 | Geographical= C N; | ||
| 0001410578-25-001112 | 20241231 | Assets | 1661000.0000 | USD | 0 | us-gaap/2024 | Geographical= D E; | ||
| 0001410578-25-001112 | 20241231 | Assets Current | 69065000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Common Stock No Par Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Common Stock Shares Issued | 30039809.0000 | shares | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Common Stock Shares Outstanding | 30039809.0000 | shares | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Current Income Tax Expense Benefit | 40000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Depreciation | 641000.0000 | USD | 4 | us-gaap/2024 | Geographical= U S; | ||
| 0001410578-25-001112 | 20250331 | Depreciation | 13000.0000 | USD | 1 | us-gaap/2024 | Geographical= C A; | ||
| 0001410578-25-001112 | 20250331 | Interest Income Expense Nonoperating Net | 445000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Liabilities And Stockholders Equity | 70234000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Accounts Payable Current | 1048000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | 2742000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 767000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001410578-25-001112 | 20250331 | Assets | 115000.0000 | USD | 0 | us-gaap/2024 | Geographical= C N; | ||
| 0001410578-25-001112 | 20250331 | Assets | 6265000.0000 | USD | 0 | us-gaap/2024 | Geographical= U S; | ||
| 0001410578-25-001112 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 26213000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 54912000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Change In Amortized Cost Of Trade And Other Receivable | -68000.0000 | USD | 1 | 0001410578-25-001112 | |||
| 0001410578-25-001112 | 20241231 | Common Stock Shares Issued | 30039809.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001410578-25-001112 | 20241231 | Common Stock Value | 281552000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Comprehensive Income Net Of Tax | -10621000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Depreciation | 199000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Earnings Per Share Basic | 0.3600 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 94000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Finite Lived Intangible Assets Net | 214000.0000 | USD | 0 | us-gaap/2024 | Geographical= C A; | ||
| 0001410578-25-001112 | 20240331 | Foreign Currency Transaction Gain Loss Before Tax | 870000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Gross Profit | 866000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -10683000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Increase Decrease In Accounts And Other Receivables | -1325000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Interest And Accretion Expense | 48000.0000 | USD | 1 | 0001410578-25-001112 | |||
| 0001410578-25-001112 | 20240331 | Interest Income Expense Nonoperating Net | 462000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Inventory Net | 5801000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Liabilities | 9812000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Long Term Debt Noncurrent | 2924000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Long Term Debt Noncurrent | 4486000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Net Cash Provided By Used In Financing Activities | 20456000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Operating Lease Right Of Use Asset | 342000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Operating Lease Right Of Use Asset | 342000.0000 | USD | 0 | us-gaap/2024 | Geographical= C A; | ||
| 0001410578-25-001112 | 20240331 | Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Retained Earnings Accumulated Deficit | -255894000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Revenues | 177000.0000 | USD | 1 | us-gaap/2024 | Geographical= D E; Product Or Service= Recurring Non Capital; | ||
| 0001410578-25-001112 | 20240331 | Revenues | 1158000.0000 | USD | 1 | us-gaap/2024 | Geographical= U S; Product Or Service= Recurring Non Capital; | ||
| 0001410578-25-001112 | 20250331 | Revenues | 282000.0000 | USD | 1 | us-gaap/2024 | Geographical= C A; Product Or Service= Recurring Non Capital; | ||
| 0001410578-25-001112 | 20250331 | Revenues | 226000.0000 | USD | 1 | us-gaap/2024 | Geographical= D E; | ||
| 0001410578-25-001112 | 20250331 | Revenues | 226000.0000 | USD | 1 | us-gaap/2024 | Geographical= D E; Product Or Service= Recurring Non Capital; | ||
| 0001410578-25-001112 | 20250331 | Revenues | 1801000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Recurring Non Capital; | ||
| 0001410578-25-001112 | 20231231 | Stockholders Equity | 5565000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001410578-25-001112 | 20240331 | Stock Issued During Period Value New Issues | 21079000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001410578-25-001112 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 30041735.0000 | shares | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Accrued Liabilities And Other Liabilities | 3350000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 989000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001410578-25-001112 | 20240331 | Amortization Of Intangible Assets | 51000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 41180000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 15927000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Common Stock No Par Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Common Stock Value | 281641000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Deferred Income Tax Assets Net | 87000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Deferred Revenue Current | 419000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Deferred Revenue Current | 636000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Depreciation | 707000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Finite Lived Intangible Assets Net | 89000.0000 | USD | 0 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= Licensing Agreements; | ||
| 0001410578-25-001112 | 20241231 | Finite Lived Intangible Assets Net | 172000.0000 | USD | 0 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= Software And Software Development Costs; | ||
| 0001410578-25-001112 | 20250331 | Finite Lived Intangible Assets Net | 84000.0000 | USD | 0 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= Licensing Agreements; | ||
| 0001410578-25-001112 | 20250331 | Gross Profit | 1853000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Increase Decrease In Prepaid Expense And Deposits Current | -467000.0000 | USD | 1 | 0001410578-25-001112 | |||
| 0001410578-25-001112 | 20241231 | Liabilities Current | 6565000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Long Term Debt Current | 1737000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Net Cash Provided By Used In Financing Activities | -290000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Nonoperating Income Expense | 1332000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Other Liabilities Noncurrent | 72000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Property Plant And Equipment Net | 79000.0000 | USD | 0 | us-gaap/2024 | Geographical= C A; | ||
| 0001410578-25-001112 | 20240331 | Revenues | 177000.0000 | USD | 1 | us-gaap/2024 | Geographical= D E; | ||
| 0001410578-25-001112 | 20250331 | Revenues | 1543000.0000 | USD | 1 | us-gaap/2024 | Geographical= U S; | ||
| 0001410578-25-001112 | 20231231 | Stockholders Equity | -217354000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001410578-25-001112 | 20240331 | Stockholders Equity | 4596000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001410578-25-001112 | 20250331 | Stockholders Equity | 50790000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Stockholders Equity | 22198000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001410578-25-001112 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 30041735.0000 | shares | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Accounts Payable Current | 1317000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 989000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Amortization Of Intangible Assets | 47000.0000 | USD | 1 | us-gaap/2024 | Geographical= C A; | ||
| 0001410578-25-001112 | 20241231 | Assets | 3387000.0000 | USD | 0 | us-gaap/2024 | Geographical= F I; | ||
| 0001410578-25-001112 | 20231231 | Common Stock Shares Issued | 21370565.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001410578-25-001112 | 20250331 | Common Stock Shares Issued | 30053142.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001410578-25-001112 | 20241231 | Depreciation | 66000.0000 | USD | 4 | us-gaap/2024 | Geographical= C A; | ||
| 0001410578-25-001112 | 20240331 | Earnings Per Share Basic | 0.2700 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Earnings Per Share Diluted | 0.3600 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -960000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Net Cash Provided By Used In Operating Activities | -4529000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Non Cash Lease Expense Adjustment | 9000.0000 | USD | 1 | 0001410578-25-001112 | |||
| 0001410578-25-001112 | 20250331 | Nonoperating Income Expense | 483000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Operating Expenses | 8743000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Operating Income Loss | -7877000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Operating Income Loss | -11166000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Operating Lease Liability Current | 257000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Operating Lease Liability Noncurrent | 203000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -969000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Payments Of Financing Costs | 1859000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Prepaid Expense And Deposits Current | 1307000.0000 | USD | 0 | 0001410578-25-001112 | |||
| 0001410578-25-001112 | 20241231 | Property Plant And Equipment Net | 425000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Repayments Of Long Term Debt | 1978000.0000 | USD | 4 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Research And Development Expense | 3945000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Revenues | 1439000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Revenues | 104000.0000 | USD | 1 | us-gaap/2024 | Geographical= C A; Product Or Service= Recurring Non Capital; | ||
| 0001410578-25-001112 | 20250331 | Revenues | 2621000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Share Based Compensation | 767000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20231231 | Stockholders Equity | 20808000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001410578-25-001112 | 20241231 | Stockholders Equity | 281552000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001410578-25-001112 | 20250331 | Stockholders Equity | -255894000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001410578-25-001112 | 20250331 | Stock Issued During Period Value Share Based Compensation | -89000.0000 | USD | 1 | us-gaap/2024 | Award Type= Restricted Stock Units R S U; Equity Components= Additional Paid In Capital; | ||
| 0001410578-25-001112 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 24295749.0000 | shares | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Net Income Loss | -6585000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Operating Lease Liability Noncurrent | 136000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | 103000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | 103000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001410578-25-001112 | 20250331 | Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Other Liabilities Noncurrent | 71000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Proceeds From Issuance Of Common Stock | 22938000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Profit Loss | -6585000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Revenues | 852000.0000 | USD | 1 | us-gaap/2024 | Geographical= C A; | ||
| 0001410578-25-001112 | 20250331 | Revenues | 820000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Capital Equipment; | ||
| 0001410578-25-001112 | 20241231 | Stockholders Equity | 2742000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001410578-25-001112 | 20250331 | Stockholders Equity | 281641000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001410578-25-001112 | 20250331 | Stock Issued During Period Shares Share Based Compensation | 13333.0000 | shares | 1 | us-gaap/2024 | Award Type= Restricted Stock Units R S U; Equity Components= Common Stock; | ||
| 0001410578-25-001112 | 20240331 | Stock Issued During Period Value New Issues | 21079000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Assets | 49910000.0000 | USD | 0 | us-gaap/2024 | Geographical= C A; | ||
| 0001410578-25-001112 | 20250331 | Additional Paid In Capital | 22198000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Assets | 6351000.0000 | USD | 0 | us-gaap/2024 | Geographical= U S; | ||
| 0001410578-25-001112 | 20250331 | Assets Current | 59912000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Cash And Cash Equivalents At Carrying Value | 46433000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -8573000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Comprehensive Income Net Of Tax | -7554000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Cost Of Revenue | 573000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Finite Lived Intangible Assets Net | 130000.0000 | USD | 0 | us-gaap/2024 | Finite Lived Intangible Assets By Major Class= Software And Software Development Costs; | ||
| 0001410578-25-001112 | 20240331 | Income Taxes Paid Net | 14000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Increase Decrease In Inventories | 984000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Interest Paid Financing Activities | 159000.0000 | USD | 1 | 0001410578-25-001112 | |||
| 0001410578-25-001112 | 20250331 | Inventory Net | 6795000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Liabilities Current | 5295000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Operating Lease Liability Current | 261000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -969000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001410578-25-001112 | 20250331 | Prepaid Expense And Deposits Current | 718000.0000 | USD | 0 | 0001410578-25-001112 | |||
| 0001410578-25-001112 | 20250331 | Property Plant And Equipment Net | 309000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Property Plant And Equipment Net | 230000.0000 | USD | 0 | us-gaap/2024 | Geographical= U S; | ||
| 0001410578-25-001112 | 20240331 | Revenues | 1158000.0000 | USD | 1 | us-gaap/2024 | Geographical= U S; | ||
| 0001410578-25-001112 | 20240331 | Revenues | 1439000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Recurring Non Capital; | ||
| 0001410578-25-001112 | 20250331 | Revenues | 570000.0000 | USD | 1 | us-gaap/2024 | Geographical= C A; Product Or Service= Capital Equipment; | ||
| 0001410578-25-001112 | 20241231 | Stockholders Equity | 60422000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Stock Issued During Period Value Share Based Compensation | 89000.0000 | USD | 1 | us-gaap/2024 | Award Type= Restricted Stock Units R S U; Equity Components= Common Stock; | ||
| 0001410578-25-001112 | 20250331 | Accounts And Other Receivables Net Current | 5966000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 767000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Assets | 70234000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Assets | 1815000.0000 | USD | 0 | us-gaap/2024 | Geographical= D E; | ||
| 0001410578-25-001112 | 20241231 | Contract With Customer Liability Noncurrent | 49000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Cost Of Revenue | 768000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Deferred Income Tax Assets Net | 87000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Finite Lived Intangible Assets Net | 214000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Increase Decrease In Accounts And Other Receivables | -1090000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -570000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Increase Decrease In Accounts Payable And Accrued Liabilities | 300000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Increase Decrease In Inventories | 180000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Increase Decrease In Prepaid Expense And Deposits Current | -592000.0000 | USD | 1 | 0001410578-25-001112 | |||
| 0001410578-25-001112 | 20250331 | Repayments Of Long Term Debt | 290000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Research And Development Expense | 4808000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Share Based Compensation | 989000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20231231 | Stockholders Equity | 222205000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001410578-25-001112 | 20241231 | Stockholders Equity | 21298000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001410578-25-001112 | 20241231 | Stockholders Equity | -245170000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001410578-25-001112 | 20241231 | Accounts And Other Receivables Net Current | 7045000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Accrued Liabilities And Other Liabilities | 2835000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Additional Paid In Capital | 21298000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Assets | 58743000.0000 | USD | 0 | us-gaap/2024 | Geographical= C A; | ||
| 0001410578-25-001112 | 20250331 | Assets | 60864000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Assets | 2759000.0000 | USD | 0 | us-gaap/2024 | Geographical= F I; | ||
| 0001410578-25-001112 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 46433000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Common Stock Shares Issued | 30053142.0000 | shares | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Common Stock Shares Outstanding | 30053142.0000 | shares | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Current Income Tax Expense Benefit | 41000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Depreciation | 116000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Earnings Per Share Diluted | 0.2700 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Finite Lived Intangible Assets Net | 261000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Income Tax Expense Benefit | 40000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Income Tax Expense Benefit | 41000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable | 14000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Interest And Accretion Expense | 169000.0000 | USD | 1 | 0001410578-25-001112 | |||
| 0001410578-25-001112 | 20250331 | Liabilities | 10074000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Net Income Loss | -10724000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001410578-25-001112 | 20240331 | Non Cash Lease Expense Adjustment | 11000.0000 | USD | 1 | 0001410578-25-001112 | |||
| 0001410578-25-001112 | 20250331 | Operating Expenses | 13019000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Operating Lease Right Of Use Asset | 396000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20241231 | Operating Lease Right Of Use Asset | 396000.0000 | USD | 0 | us-gaap/2024 | Geographical= C A; | ||
| 0001410578-25-001112 | 20241231 | Property Plant And Equipment Net | 93000.0000 | USD | 0 | us-gaap/2024 | Geographical= C A; | ||
| 0001410578-25-001112 | 20250331 | Revenues | 1293000.0000 | USD | 1 | us-gaap/2024 | Geographical= U S; Product Or Service= Recurring Non Capital; | ||
| 0001410578-25-001112 | 20240331 | Selling General And Administrative Expense | 4798000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20250331 | Selling General And Administrative Expense | 8211000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20231231 | Stockholders Equity | 31224000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Stockholders Equity | 45516000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001112 | 20240331 | Stockholders Equity | 21575000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001410578-25-001112 | 20240331 | Stockholders Equity | 243284000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001410578-25-001112 | 20240331 | Stockholders Equity | -223939000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001410578-25-001112 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 24295749.0000 | shares | 1 | us-gaap/2024 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Change In Amortized Cost Of Trade And Other Receivable | 0001410578-25-001112 | 1 | 0 | monetary | D | D | Change in Amortized Cost of Trade And Other Receivable | Amount representing Change in amortized cost of trade and other receivables. |
| Increase Decrease In Prepaid Expense And Deposits Current | 0001410578-25-001112 | 1 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Deposits, Current | The increase (decrease) during the reporting period of amount of asset related to consideration paid in advance for costs and deposits that provide economic benefits within a future period of one year or the normal operating cycle, if longer. |
| Deferred Income Tax Assets Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Deferred Income Tax Assets, Net | Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting. |
| Deferred Revenue Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Deferred Revenue, Current | Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Interest Income Expense Nonoperating Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Income (Expense), Nonoperating | Amount of interest income (expense) classified as nonoperating. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Prepaid Expense And Deposits Current | 0001410578-25-001112 | 1 | 0 | monetary | I | D | Prepaid Expense and Deposits, Current | Amount of asset related to consideration paid in advance for costs and deposits that provide economic benefits within a future period of one year or the normal operating cycle, if longer. |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | D | D | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Stock Issued During Period Value Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | C | Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture | Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Accrued Liabilities And Other Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Liabilities and Other Liabilities | Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other. |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Gross Profit | us-gaap/2024 | 0 | 0 | monetary | D | C | Gross Profit | Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. |
| Increase Decrease In Accounts And Other Receivables | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts and Other Receivables | The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables. |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax | us-gaap/2024 | 0 | 0 | monetary | D | D | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax | Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. |
| Accounts And Other Receivables Net Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Accounts and Other Receivables, Net, Current | Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer. |
| Interest And Accretion Expense | 0001410578-25-001112 | 1 | 0 | monetary | D | D | Interest And Accretion Expense | Amount representing interest and accretion expense during the period. |
| Cost Of Revenue | us-gaap/2024 | 0 | 0 | monetary | D | D | Cost of Revenue | The aggregate cost of goods produced and sold and services rendered during the reporting period. |
| Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable | The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. |
| Repayments Of Long Term Debt | us-gaap/2024 | 0 | 0 | monetary | D | C | Repayments of Long-Term Debt | The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer. |
| Selling General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Selling, General and Administrative Expense | The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Foreign Currency Transaction Gain Loss Before Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Gain (Loss), Foreign Currency Transaction, before Tax | Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction. |
| Income Taxes Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Income Taxes Paid, Net | Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax. |
| Increase Decrease In Inventories | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Inventories | The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Common Stock No Par Value | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, No Par Value | Face amount per share of no-par value common stock. | |
| Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
| Interest Paid Financing Activities | 0001410578-25-001112 | 1 | 0 | monetary | D | C | Interest Paid, Financing Activities | Amount of cash paid for interest, classified as financing activity. |
| Finite Lived Intangible Assets Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Finite-Lived Intangible Assets, Net | Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Other Liabilities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities, Noncurrent | Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Current Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Current Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations. |
| Inventory Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Inventory, Net | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. |
| Amortization Of Intangible Assets | us-gaap/2024 | 0 | 0 | monetary | D | D | Amortization of Intangible Assets | The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Revenues | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenues | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). |
| Stock Issued During Period Shares New Issues | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Contract With Customer Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Contract with Customer, Liability, Noncurrent | Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Non Cash Lease Expense Adjustment | 0001410578-25-001112 | 1 | 0 | monetary | D | C | Non-Cash Lease Expense Adjustment | Amount of non cash lease expense adjustment. |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Increase Decrease In Deferred Revenue | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Deferred Revenue | Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable. |
| Depreciation | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
| Payments Of Financing Costs | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments of Financing Costs | The cash outflow for loan and debt issuance costs. |
| Proceeds From Issuance Of Common Stock | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. |
| Stock Issued During Period Value New Issues | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
| Long Term Debt Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Long-Term Debt, Current Maturities | Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation. |
| Long Term Debt Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Long-Term Debt, Excluding Current Maturities | Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation. |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Stock Issued During Period Shares Share Based Compensation | us-gaap/2024 | 0 | 0 | shares | D | Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture | Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP). | |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001410578-25-001112 | 2 | 7 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0001410578-25-001112 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash | 0 |
| 0001410578-25-001112 | 2 | 4 | BS | 0 | H | Accounts And Other Receivables Net Current | us-gaap/2024 | Trade and other receivables, net (note 3) | 0 |
| 0001410578-25-001112 | 2 | 5 | BS | 0 | H | Inventory Net | us-gaap/2024 | Inventory (note 4) | 0 |
| 0001410578-25-001112 | 2 | 6 | BS | 0 | H | Prepaid Expense And Deposits Current | 0001410578-25-001112 | Prepaid expenses and deposits | 0 |
| 0001410578-25-001112 | 2 | 8 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net (note 5) | 0 |
| 0001410578-25-001112 | 2 | 9 | BS | 0 | H | Finite Lived Intangible Assets Net | us-gaap/2024 | Intangible assets, net (note 6) | 0 |
| 0001410578-25-001112 | 2 | 10 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Right-of-use assets, net | 0 |
| 0001410578-25-001112 | 2 | 11 | BS | 0 | H | Deferred Income Tax Assets Net | us-gaap/2024 | Deferred tax assets, net | 0 |
| 0001410578-25-001112 | 2 | 12 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0001410578-25-001112 | 2 | 15 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0001410578-25-001112 | 2 | 16 | BS | 0 | H | Accrued Liabilities And Other Liabilities | us-gaap/2024 | Accrued expenses and other current liabilities (note 7) | 0 |
| 0001410578-25-001112 | 2 | 17 | BS | 0 | H | Deferred Revenue Current | us-gaap/2024 | Deferred revenue | 0 |
| 0001410578-25-001112 | 2 | 18 | BS | 0 | H | Long Term Debt Current | us-gaap/2024 | Long-term debt (note 8) | 0 |
| 0001410578-25-001112 | 2 | 19 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Lease liabilities | 0 |
| 0001410578-25-001112 | 2 | 20 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0001410578-25-001112 | 2 | 21 | BS | 0 | H | Contract With Customer Liability Noncurrent | us-gaap/2024 | Deferred revenue | 0 |
| 0001410578-25-001112 | 2 | 22 | BS | 0 | H | Long Term Debt Noncurrent | us-gaap/2024 | Long-term debt (note 8) | 0 |
| 0001410578-25-001112 | 2 | 23 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Lease liabilities | 0 |
| 0001410578-25-001112 | 2 | 24 | BS | 0 | H | Other Liabilities Noncurrent | us-gaap/2024 | Other non-current liabilities | 0 |
| 0001410578-25-001112 | 2 | 25 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0001410578-25-001112 | 2 | 27 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common shares, no par value, unlimited shares authorized, 30,053,142 and 30,039,809 issued and outstanding at March 31, 2025 and December 31, 2024, respectively (note 9) | 0 |
| 0001410578-25-001112 | 2 | 28 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001410578-25-001112 | 2 | 29 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive income | 0 |
| 0001410578-25-001112 | 2 | 30 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001410578-25-001112 | 2 | 31 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total shareholders' equity | 0 |
| 0001410578-25-001112 | 2 | 32 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and shareholders' equity | 0 |
| 0001410578-25-001112 | 3 | 1 | BS | 1 | H | Common Stock No Par Value | us-gaap/2024 | Common stock, No par value | 0 |
| 0001410578-25-001112 | 3 | 3 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, Shares issued | 0 |
| 0001410578-25-001112 | 3 | 4 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0001410578-25-001112 | 4 | 7 | IS | 0 | H | Revenues | us-gaap/2024 | Revenue (note 11) | 0 |
| 0001410578-25-001112 | 4 | 8 | IS | 0 | H | Cost Of Revenue | us-gaap/2024 | Cost of sales | 0 |
| 0001410578-25-001112 | 4 | 9 | IS | 0 | H | Gross Profit | us-gaap/2024 | Gross profit | 0 |
| 0001410578-25-001112 | 4 | 11 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0001410578-25-001112 | 4 | 12 | IS | 0 | H | Selling General And Administrative Expense | us-gaap/2024 | Selling, general and administrative | 0 |
| 0001410578-25-001112 | 4 | 13 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0001410578-25-001112 | 4 | 14 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Operating loss | 1 |
| 0001410578-25-001112 | 4 | 16 | IS | 0 | H | Interest Income Expense Nonoperating Net | us-gaap/2024 | Net finance (income) expense | 1 |
| 0001410578-25-001112 | 4 | 17 | IS | 0 | H | Foreign Currency Transaction Gain Loss Before Tax | us-gaap/2024 | Net foreign exchange (gain) loss | 1 |
| 0001410578-25-001112 | 4 | 18 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Total other (income) expenses | 1 |
| 0001410578-25-001112 | 4 | 19 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Net loss before income taxes | 1 |
| 0001410578-25-001112 | 4 | 20 | IS | 0 | H | Current Income Tax Expense Benefit | us-gaap/2024 | Income tax expense | 0 |
| 0001410578-25-001112 | 4 | 21 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Total income tax expense | 0 |
| 0001410578-25-001112 | 4 | 22 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss attributed to shareholders for the period | 1 |
| 0001410578-25-001112 | 4 | 25 | IS | 0 | H | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | Foreign currency translation adjustment | 1 |
| 0001410578-25-001112 | 4 | 26 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Net loss and other comprehensive loss for the period | 1 |
| 0001410578-25-001112 | 4 | 28 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Basic net loss per common share | 0 |
| 0001410578-25-001112 | 4 | 29 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Diluted net loss per common share | 0 |
| 0001410578-25-001112 | 4 | 30 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Basic weighted average common shares outstanding | 0 |
| 0001410578-25-001112 | 4 | 31 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Diluted weighted average common shares outstanding | 0 |
| 0001410578-25-001112 | 5 | 12 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance at beginning | 0 |
| 0001410578-25-001112 | 5 | 13 | EQ | 0 | H | Common Stock Shares Issued | us-gaap/2024 | Balance at beginning (In shares) | 0 |
| 0001410578-25-001112 | 5 | 14 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net Income (Loss) | 0 |
| 0001410578-25-001112 | 5 | 15 | EQ | 0 | H | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | Cumulative translation adjustment - net of tax of $nil | 0 |
| 0001410578-25-001112 | 5 | 16 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2024 | Shares issued in public offering and private placement | 0 |
| 0001410578-25-001112 | 5 | 17 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Shares issued in public offering and private placement (in shares) | 0 |
| 0001410578-25-001112 | 5 | 18 | EQ | 0 | H | Stock Issued During Period Value Share Based Compensation | us-gaap/2024 | Vesting of share-based payment award, equity instruments other than options | 0 |
| 0001410578-25-001112 | 5 | 19 | EQ | 0 | H | Stock Issued During Period Shares Share Based Compensation | us-gaap/2024 | Vesting of share-based payment award, equity instruments other than options (in shares) | 0 |
| 0001410578-25-001112 | 5 | 20 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Share-based compensation (note 10) | 0 |
| 0001410578-25-001112 | 5 | 21 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance at ending | 0 |
| 0001410578-25-001112 | 5 | 22 | EQ | 0 | H | Common Stock Shares Issued | us-gaap/2024 | Balance at ending (in shares) | 0 |
| 0001410578-25-001112 | 6 | 1 | EQ | 1 | H | Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax | us-gaap/2024 | Cumulative translation adjustment, tax | 0 |
| 0001410578-25-001112 | 7 | 2 | CF | 0 | H | Profit Loss | us-gaap/2024 | Net loss for the period | 0 |
| 0001410578-25-001112 | 7 | 4 | CF | 0 | H | Depreciation | us-gaap/2024 | Depreciation of property and equipment (note 5) | 0 |
| 0001410578-25-001112 | 7 | 5 | CF | 0 | H | Amortization Of Intangible Assets | us-gaap/2024 | Amortization of intangible assets (note 6) | 0 |
| 0001410578-25-001112 | 7 | 6 | CF | 0 | H | Non Cash Lease Expense Adjustment | 0001410578-25-001112 | Non-cash lease expense adjustment | 1 |
| 0001410578-25-001112 | 7 | 7 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Share-based compensation (note 10) | 0 |
| 0001410578-25-001112 | 7 | 8 | CF | 0 | H | Interest And Accretion Expense | 0001410578-25-001112 | Interest and accretion expense | 0 |
| 0001410578-25-001112 | 7 | 9 | CF | 0 | H | Change In Amortized Cost Of Trade And Other Receivable | 0001410578-25-001112 | Change in amortized cost of trade and other receivables | 0 |
| 0001410578-25-001112 | 7 | 11 | CF | 0 | H | Increase Decrease In Accounts And Other Receivables | us-gaap/2024 | Trade and other receivables (note 3) | 1 |
| 0001410578-25-001112 | 7 | 12 | CF | 0 | H | Increase Decrease In Inventories | us-gaap/2024 | Inventory (note 4) | 1 |
| 0001410578-25-001112 | 7 | 13 | CF | 0 | H | Increase Decrease In Prepaid Expense And Deposits Current | 0001410578-25-001112 | Prepaid expenses and deposits | 1 |
| 0001410578-25-001112 | 7 | 14 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accounts payable, accrued expenses and other liabilities (note 7) | 0 |
| 0001410578-25-001112 | 7 | 15 | CF | 0 | H | Increase Decrease In Deferred Revenue | us-gaap/2024 | Deferred revenue | 0 |
| 0001410578-25-001112 | 7 | 16 | CF | 0 | H | Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable | us-gaap/2024 | Income taxes payable | 0 |
| 0001410578-25-001112 | 7 | 17 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0001410578-25-001112 | 7 | 19 | CF | 0 | H | Repayments Of Long Term Debt | us-gaap/2024 | Repayments of long-term debt (note 8) | 1 |
| 0001410578-25-001112 | 7 | 20 | CF | 0 | H | Proceeds From Issuance Of Common Stock | us-gaap/2024 | Issuance of commons shares (note 10) | 0 |
| 0001410578-25-001112 | 7 | 21 | CF | 0 | H | Payments Of Financing Costs | us-gaap/2024 | Payments of financing costs (note 10) | 1 |
| 0001410578-25-001112 | 7 | 22 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by (used in) financing activities | 0 |
| 0001410578-25-001112 | 7 | 23 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | Net increase (decrease) in cash and cash equivalents | 0 |
| 0001410578-25-001112 | 7 | 24 | CF | 0 | H | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Effect of exchange rate changes on cash | 0 |
| 0001410578-25-001112 | 7 | 25 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, beginning of period | 0 |
| 0001410578-25-001112 | 7 | 26 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash, end of period | 0 |
| 0001410578-25-001112 | 7 | 28 | CF | 0 | H | Interest Paid Financing Activities | 0001410578-25-001112 | Interest paid, included in financing activities | 0 |
| 0001410578-25-001112 | 7 | 29 | CF | 0 | H | Income Taxes Paid Net | us-gaap/2024 | Income taxes paid, included in operating activities | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |